1. Home
  2. LGND vs ATKR Comparison

LGND vs ATKR Comparison

Compare LGND & ATKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • ATKR
  • Stock Information
  • Founded
  • LGND 1987
  • ATKR 1959
  • Country
  • LGND United States
  • ATKR United States
  • Employees
  • LGND 68
  • ATKR N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • ATKR Industrial Machinery/Components
  • Sector
  • LGND Health Care
  • ATKR Miscellaneous
  • Exchange
  • LGND Nasdaq
  • ATKR Nasdaq
  • Market Cap
  • LGND 2.2B
  • ATKR 2.2B
  • IPO Year
  • LGND 1992
  • ATKR 2016
  • Fundamental
  • Price
  • LGND $147.40
  • ATKR $54.61
  • Analyst Decision
  • LGND Strong Buy
  • ATKR Hold
  • Analyst Count
  • LGND 8
  • ATKR 6
  • Target Price
  • LGND $144.71
  • ATKR $79.80
  • AVG Volume (30 Days)
  • LGND 139.7K
  • ATKR 691.8K
  • Earning Date
  • LGND 08-05-2025
  • ATKR 08-05-2025
  • Dividend Yield
  • LGND N/A
  • ATKR 2.40%
  • EPS Growth
  • LGND N/A
  • ATKR N/A
  • EPS
  • LGND N/A
  • ATKR 3.22
  • Revenue
  • LGND $181,488,000.00
  • ATKR $2,886,664,000.00
  • Revenue This Year
  • LGND $18.41
  • ATKR N/A
  • Revenue Next Year
  • LGND $18.87
  • ATKR $2.01
  • P/E Ratio
  • LGND N/A
  • ATKR $17.09
  • Revenue Growth
  • LGND 53.40
  • ATKR N/A
  • 52 Week Low
  • LGND $81.74
  • ATKR $49.92
  • 52 Week High
  • LGND $129.90
  • ATKR $105.28
  • Technical
  • Relative Strength Index (RSI)
  • LGND 68.73
  • ATKR 24.43
  • Support Level
  • LGND $132.21
  • ATKR $54.61
  • Resistance Level
  • LGND $149.21
  • ATKR $58.43
  • Average True Range (ATR)
  • LGND 5.37
  • ATKR 3.09
  • MACD
  • LGND 0.53
  • ATKR -2.89
  • Stochastic Oscillator
  • LGND 83.70
  • ATKR 4.09

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About ATKR Atkore Inc.

Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments; Electrical and Safety and Infrastructure. Net sales are highest in the electrical business line. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tubes, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets. Geographically, the company derives its key revenue from the United States.

Share on Social Networks: